Mold-Tek Packaging Q2 Review - Strong Growth Momentum To Continue: Systematix

Mold-Tek Packaging Q2 Review - Strong Growth Momentum To Continue: Systematix

<div class="paragraphs"><p>Mold-Tek dispenser pump models. (Image: Company website)</p></div>
Mold-Tek dispenser pump models. (Image: Company website)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Report

Mold-Tek Packaging Ltd.'s Q2 FY22 results were broadly in line with our estimates with sales/Ebitda/PAT growth of 34%/24%/31% YoY and 19%/27%/46% QoQ.

The revenue growth was led by paints (45% YoY) and food and FMCG - F&F segment (23% YoY). The overall volume grew 8% YoY driven by the paints volume (20% YoY).

The operating profit margin improved to 20.1% vs. 18.9% QoQ and Ebitda/kg stood at Rs 42.5 versus Rs 42.1 QoQ on account of operating leverage as Vizag and Mysore capacity utilisation was 90%+ and the in-house installation of the printing flexography machine that reduced outsourcing.

The management has guided for higher Ebitda/kg of Rs 40-42 versus Rs 36-38 earlier. Factoring Q2 FY22 results and improved guidance, we increase our FY22 earnings by 6% but keep our FY23 estimates unchanged. We estimate Ebitda/PAT CAGR of 23%/30% during FY21-23E led by

  • strong demand and capacity addition in the paint segment

  • new category (sweets box) and client additions in the F&F segment

  • healthy order book in the lube segment

  • strong traction in the newly incubated pumps division

Click on the attachment to read the full report:

Mold-Tek Packaging - 2QFY22 - RU - 01-11-2021 - Systematix.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.